nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advantages of adjuvant chemotherapy using S-1 following minimally invasive gastrectomy for gastric cancer versus open surgery: a propensity score-matched analysis
|
Ri, Motonari |
|
|
28 |
1 |
p. 122-130 |
artikel |
2 |
Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancer
|
Iden, Cecilie Riis |
|
|
28 |
1 |
p. 83-95 |
artikel |
3 |
Clinical epidemiology of the endoscopic, laparoscopic, and surgical resection of malignant gastric tumors in Japan, 2014–2021: a retrospective study using open data from a national claims database
|
Sako, Akahito |
|
|
28 |
1 |
p. 1-11 |
artikel |
4 |
Correction: Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study)
|
Kawakami, Hisato |
|
|
28 |
1 |
p. 62 |
artikel |
5 |
Decorin as a key marker of desmoplastic cancer-associated fibroblasts mediating first-line immune checkpoint blockade resistance in metastatic gastric cancer
|
Kim, Ki Tae |
|
|
28 |
1 |
p. 12-26 |
artikel |
6 |
Morbidity and quality of life of totally laparoscopic versus laparoscopy-assisted distal gastrectomy for early gastric cancer: a multi-center prospective randomized controlled trial (CKLASS01)
|
Zhang, Yu |
|
|
28 |
1 |
p. 131-144 |
artikel |
7 |
Neoadjuvant chemotherapy in relation to long-term mortality in individuals cured of gastric adenocarcinoma
|
Leijonmarck, Wilhelm |
|
|
28 |
1 |
p. 96-101 |
artikel |
8 |
Predictors of tolerability for postoperative adjuvant S1 plus docetaxel chemotherapy for gastric cancer: a multicenter retrospective study
|
Toyota, Kazuhiro |
|
|
28 |
1 |
p. 102-111 |
artikel |
9 |
Prognostic and predictive factors for the efficacy and safety of trastuzumab deruxtecan in HER2-positive gastric or gastroesophageal junction cancer
|
Jubashi, Amane |
|
|
28 |
1 |
p. 63-73 |
artikel |
10 |
Prognostic significance of tertiary lymphoid structures in gastric neuroendocrine carcinoma with association to delta-like ligand 3 and neuroendocrine expressions
|
Ahn, Bokyung |
|
|
28 |
1 |
p. 27-40 |
artikel |
11 |
Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study)
|
Kawakami, Hisato |
|
|
28 |
1 |
p. 51-61 |
artikel |
12 |
Short-term outcomes of a phase II trial of perioperative capecitabine plus oxaliplatin therapy for advanced gastric cancer with extensive lymph node metastases (OGSG1701)
|
Kimura, Yutaka |
|
|
28 |
1 |
p. 112-121 |
artikel |
13 |
Survival outcomes of patients with gastric cancer treated with first-line nivolumab plus chemotherapy based on claudin 18.2 expression
|
Kim, Hyung-Don |
|
|
28 |
1 |
p. 74-82 |
artikel |
14 |
Volume of hepatoid component and intratumor M2 macrophages predict prognosis in patients with hepatoid adenocarcinoma of the stomach
|
Taniguchi, Yoshiaki |
|
|
28 |
1 |
p. 41-50 |
artikel |